Y
Yoshitaka Fujii
Researcher at Nagoya City University
Publications - 306
Citations - 22300
Yoshitaka Fujii is an academic researcher from Nagoya City University. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 59, co-authored 304 publications receiving 21040 citations.
Papers
More filters
Journal ArticleDOI
Predictors of response to exemestane as primary endocrine therapy in estrogen receptor–positive breast cancer
Hiroko Yamashita,Satoru Takahashi,Yukashi Ito,Toshinari Yamashita,Yoshiaki Ando,Tatsuya Toyama,Hiroshi Sugiura,Nobuyasu Yoshimoto,Shunzo Kobayashi,Yoshitaka Fujii,Hirotaka Iwase +10 more
TL;DR: High‐level expression of AIB1 and phosphorylation of Akt Ser473 were significantly associated with a better response to exemestane, suggesting that these factors could be considered as predictors of exemstane response.
Journal ArticleDOI
miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer
Yumi Endo,Tatsuya Toyama,Satoru Takahashi,Nobuyasu Yoshimoto,Mai Iwasa,Tomoko Asano,Yoshitaka Fujii,Hiroko Yamashita +7 more
TL;DR: Examination of expression profiles of microRNAs (miRNAs) and mRNAs in ER-positive breast cancer tissue were compared and it was suggested that miR-1290 and its potential targets might be associated with characteristics of ER- positive breast cancer.
Journal ArticleDOI
Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer
Hidefumi Sasaki,Haruhiro Yukiue,Yoshihiro Kobayashi,Masayuki Tanahashi,Satoru Moriyama,Yoshiaki Nakashima,Ichiro Fukai,Masanobu Kiriyama,Yosuke Yamakawa,Yoshitaka Fujii +9 more
TL;DR: It is suggested that cdc25B may predict poor survival in patients with non-small cell lung cancer (NSCLC) and affect their clinical outcome.
Journal ArticleDOI
Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma
Yoichiro Mori,Hideyuki Ishiguro,Yoshiyuki Kuwabara,Masahiro Kimura,Akira Mitsui,Horoki Kurehara,Ryota Mori,Keisuke Tomoda,Ryo Ogawa,Takeyasu Katada,Koshiro Harata,Yoshitaka Fujii +11 more
TL;DR: It is concluded that ECRG4 mRNA expression level could be a candidate for an independent prognostic factor for ESCC patients on the basis of multivariate analysis.
Journal ArticleDOI
KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
Keisuke Yokota,Hidefumi Sasaki,Katsuhiro Okuda,Shigeki Shimizu,Masayuki Shitara,Y. U. Hikosaka,Satoru Moriyama,Motoki Yano,Yoshitaka Fujii +8 more
TL;DR: KIF5B/RET fusion genes as a driver somatic mutation of lung adenocarcinomas and chimeric oncogene may be a promising molecular target for the personalized diagnosis and treatment of NSCLC.